Clinical trials
Active, not recruiting Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Duke University | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Aarhus University Hospital | 1 |
| Centro Cardiologico Monzino | 1 |
| Changi General Hospital | 1 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 1 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 1 |
| JW Pharmaceutical | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 24 |
| Cardiovascular Diseases | 6 |
| Hypertension | 5 |
| Dyslipidemias | 4 |
| Hyperlipidemias | 4 |
| Atherosclerosis | 3 |
| Diabetes Mellitus | 3 |
| Obesity | 3 |
| Coronary Artery Disease | 2 |
| Homozygous Familial Hypercholesterolemia | 2 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.